DRI Healthcare Trust (DHT-UN.TO) TSX
18.17
+0.22(+1.23%)
Currency In CAD
- General
- Statistics
- Historical Data
- Profile
- Financials
DRI Healthcare Trust
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
36
First IPO Date
February 11, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Babak Farahmand | Executive Vice President of Asset Operations & Analytics - DRI Capital Inc. | 0 | N/A |
| Emmanuel Coeytaux | Executive Vice President of Strategy | 0 | N/A |
| Zaheed Mawani | Chief Financial Officer | 0 | N/A |
| Lee Schechter | Senior Vice President of Research & Investments | 0 | N/A |
| Navin Cyriac Jacob | Executive Vice President, Head of Investments & Research - DRI Capital Inc. | 0 | N/A |
Description
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
